YouTube video by PKDFoundation

ADPKD therapies are moving beyond tolvaptan. Explore the gene-directed, metabolic and PAPP-A drugs now in clinical trials.

Polycystic kidney disease (PKD) is a genetic disorder characterized by the growth of cysts in the kidneys. These cysts can enlarge the kidneys and impair their function over time, leading to symptoms ...

Current funded research The goal of the Research Grant and Fellowship Programs will fund critical research to increase understanding of the genetic and pathological processes involved in PKD and to ac...

Explore options for autosomal dominant polycystic kidney disease (ADPKD) through clinical research.

On June 11th, 2026, the PKD community lost a friend, advocate, and scientific pioneer with the passing of Dr. James Calvet, Professor Emeritus of the University of Kansas Medical Center. Jim entered t...

On June 11th, 2026, the PKD community lost a friend, advocate, and scientific pioneer with the passing of Dr. James Calvet, Professor Emeritus of the University of Kansas Medical Center. Jim entered t...

There’s hope that new federal legislation could one day help find a cure for polycystic kidney disease (PKD), one of the most common genetic disorders.

Explore options for autosomal dominant polycystic kidney disease (ADPKD) through clinical research.

First-ever PKD-specific federal legislation aims to advance the path toward new treatments and a cure for more than 500,000 Americans Kansas City, MO (6/5/2026) — The PKD Foundation applauds the intro...

This is a pivotal moment in PKD research, and your generosity will help accelerate new breakthroughs and discoveries. Donate today and your gift will be doubled. https://support.pkdcure.org/campaign/...